Evidence map›Paper›PMID 26272819›Full record

ArticleGenes & development2015

Sequential replication-coupled destruction at G1/S ensures genome stability.

Kate E Coleman, Gavin D Grant, Rachel A Haggerty, Kristen Brantley, Etsuko Shibata, Benjamin D Workman, Anindya Dutta, Dileep Varma, Jeremy E Purvis, Jeanette Gowen Cook

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2- breast tumor cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Revisiting the Function of p21International journal of molecular sciences · 2022
    Review
  11. Article
  12. USP7 and VCPCell reports · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Kate E ColemanCurriculum in Genetics and Molecular Biology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA;
Gavin D GrantDepartment of Biochemistry and Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA;
Rachel A HaggertyDepartment of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA; Curriculum in Bioinformatics and Computational Biology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA;
Kristen BrantleyDepartment of Biochemistry and Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA;
Etsuko ShibataDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA;
Benjamin D WorkmanDepartment of Biochemistry and Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA;
Anindya DuttaDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA;
Dileep VarmaDepartment of Cell and Molecular Biology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
Jeremy E PurvisDepartment of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA; Curriculum in Bioinformatics and Computational Biology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA;
Jeanette Gowen CookCurriculum in Genetics and Molecular Biology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA; Department of Biochemistry and Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA;
University of North Carolina at Chapel Hill · USUniversity of Virginia · USNorthwestern University · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Thomas P. Loughran · 1987 to 2026
$72.1M
Integrated Training in Cancer Model SystemsT32CA009156 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 1985 to 2020
$19.7M
NRSA IN GENETICST32GM007092 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEKELSKY, JEFF J. · 1985 to 2019
$5.9M
UNC Predoc Training Progr in Bioinformatics/Comp BiologyT32GM067553 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ELSTON, TIMOTHY C · 2005 to 2019
$2.5M
Post-Translational Regulation of DNA Replication Origin Licensing in Human CellsR01GM102413 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COOK, JEANETTE GOWEN · 2013 to 2021
$2.5M
Effect of anti-S phase agents on human chromosomesR01CA166054 · NCI · UNIVERSITY OF VIRGINIA · PI DUTTA, ANINDYA · 2013 to 2017
$1.6M
Dynamics of cellular senescence in single human cells Admin SupplementR00GM102372 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PURVIS, JEREMY · 2013 to 2015
$886k
Role of the Ndc80 Loop Domain and Cdt1 in Kinetochore Microtubule AttachmentsR00CA178188 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI VARMA, DILEEP · 2015 to 2017
$660k
Breast Cancer Cell Dormancy is Orchestrated by Stroma & Tissue MicroenvironmentK99CA178177 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BUSSARD, KAREN MARIE · 2013 to 2014
$188k
Linking DNA Replication Origin Licensing with Cell Cycle ProgressionF31CA165891 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COLEMAN, KATE E · 2013 to 2015
$85k
NCI NIH HHS F31 CA165891NCI NIH HHS F31CA165891NCI NIH HHS K99 CA178177NCI NIH HHS K99CA178177NCI NIH HHS P30 CA016086NCI NIH HHS P30CA016086NCI NIH HHS T32 CA009156NCI NIH HHS T32CA009156NIGMS NIH HHS R00 GM102372NIGMS NIH HHS R00GM102372NIGMS NIH HHS R01 GM102413NIGMS NIH HHS R01GM102413
6 · The paper itself

Abstract

Timely ubiquitin-mediated protein degradation is fundamental to cell cycle control, but the precise degradation order at each cell cycle phase transition is still unclear. We investigated the degradation order among substrates of a single human E3 ubiquitin ligase, CRL4(Cdt2), which mediates the S-phase degradation of key cell cycle proteins, including Cdt1, PR-Set7, and p21. Our analysis of synchronized cells and asynchronously proliferating live single cells revealed a consistent order of replication-coupled destruction during both S-phase entry and DNA repair; Cdt1 is destroyed first, whereas p21 destruction is always substantially later than that of Cdt1. These differences are attributable to the CRL4(Cdt2) targeting motif known as the PIP degron, which binds DNA-loaded proliferating cell nuclear antigen (PCNA(DNA)) and recruits CRL4(Cdt2). Fusing Cdt1's PIP degron to p21 causes p21 to be destroyed nearly concurrently with Cdt1 rather than consecutively. This accelerated degradation conferred by the Cdt1 PIP degron is accompanied by more effective Cdt2 recruitment by Cdt1 even though p21 has higher affinity for PCNA(DNA). Importantly, cells with artificially accelerated p21 degradation display evidence of stalled replication in mid-S phase and sensitivity to replication arrest. We therefore propose that sequential degradation ensures orderly S-phase progression to avoid replication stress and genome instability.

Indexed as

Genomic InstabilityProteolysisAmino Acid MotifsCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21DNA RepairDNA ReplicationG1 PhaseHumansNuclear ProteinsProliferating Cell Nuclear AntigenProtein BindingS PhaseUbiquitin-Protein LigasesCDKN1A protein, humanCDT1 protein, humanCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21DTL protein, humanNuclear ProteinsProliferating Cell Nuclear AntigenUbiquitin-Protein LigasesCDKCdt1p21replication stressS phaseubiquitin

Identifiers

PMID26272819
PMCPMC4561482
OpenAlexW2171998478

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.